These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21404039)

  • 21. Comparison of plasma histamine levels after intravenous administration of hydromorphone and morphine in dogs.
    Guedes AG; Papich MG; Rude EP; Rider MA
    J Vet Pharmacol Ther; 2007 Dec; 30(6):516-22. PubMed ID: 17991219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of buprenorphine following intravenous and intramuscular administration in male rhesus macaques (Macaca mulatta).
    Kelly KR; Pypendop BH; Christe KL
    J Vet Pharmacol Ther; 2014 Oct; 37(5):480-5. PubMed ID: 24666428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Input characteristics and bioavailability after administration of immediate and a new extended-release formulation of hydromorphone in healthy volunteers.
    Drover DR; Angst MS; Valle M; Ramaswamy B; Naidu S; Stanski DR; Verotta D
    Anesthesiology; 2002 Oct; 97(4):827-36. PubMed ID: 12357147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of oxymorphone in titi monkeys (Callicebus spp.) and rhesus macaques (Macaca mulatta).
    Kelly KR; Pypendop BH; Grayson JK; Stanley SD; Christe KL; Summers LM; Lerche NW
    J Am Assoc Lab Anim Sci; 2011 Mar; 50(2):212-20. PubMed ID: 21439215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metamorphosis of hydromorphone.
    Reisfield GM; Wilson GR
    J Opioid Manag; 2005; 1(3):139-45. PubMed ID: 17315417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the thermal antinociceptive effects and pharmacokinetics of hydromorphone hydrochloride after intramuscular administration to cockatiels (Nymphicus hollandicus).
    Houck EL; Guzman DS; Beaufrère H; Knych HK; Paul-Murphy JR
    Am J Vet Res; 2018 Aug; 79(8):820-827. PubMed ID: 30058846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydromorphone analgesia after intravenous bolus administration.
    Coda B; Tanaka A; Jacobson RC; Donaldson G; Chapman CR
    Pain; 1997 May; 71(1):41-8. PubMed ID: 9200172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence and absence of food.
    Sathyan G; Xu E; Thipphawong J; Gupta SK
    BMC Clin Pharmacol; 2007 Feb; 7():2. PubMed ID: 17270055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydromorphone: pharmacology and clinical applications in cancer patients.
    Sarhill N; Walsh D; Nelson KA
    Support Care Cancer; 2001 Mar; 9(2):84-96. PubMed ID: 11305075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective investigation of intravenous patient-controlled analgesia with hydromorphone or sufentanil: impact on mood, opioid adverse effects, and recovery.
    Yang Y; Wu J; Li H; Ye S; Xu X; Cheng L; Zhu L; Peng Z; Feng Z
    BMC Anesthesiol; 2018 Apr; 18(1):37. PubMed ID: 29636011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and Abuse Potential of Asalhydromorphone, a Novel Prodrug of Hydromorphone, After Intranasal Administration in Recreational Drug Users.
    Guenther S; Mickle TC; Barrett AC; Smith A; Braeckman R; Kelsh D; Vince B
    Pain Med; 2020 Mar; 21(3):511-520. PubMed ID: 30986302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of tramadol following intravenous and oral administration in male rhesus macaques (Macaca mulatta).
    Kelly KR; Pypendop BH; Christe KL
    J Vet Pharmacol Ther; 2015 Aug; 38(4):375-82. PubMed ID: 25488714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antinociceptive and side-effects of hydromorphone after subcutaneous administration in cats.
    Robertson SA; Wegner K; Lascelles BD
    J Feline Med Surg; 2009 Feb; 11(2):76-81. PubMed ID: 18675572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacokinetics and pharmacodynamics of intravenous hydromorphone in horses.
    Reed R; Barletta M; Mitchell K; Hanafi A; Bullington A; Knych H; Quandt J; Ryan C; Giguère S
    Vet Anaesth Analg; 2019 May; 46(3):395-404. PubMed ID: 30930095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antinociceptive effects of intravenous administration of hydromorphone hydrochloride alone or followed by buprenorphine hydrochloride or butorphanol tartrate to healthy conscious cats.
    Simon BT; Steagall PV; Monteiro BP; Troncy E; Lizarraga I
    Am J Vet Res; 2016 Mar; 77(3):245-51. PubMed ID: 26919594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OROS® hydromorphone in chronic pain management: when drug delivery technology matches clinical needs.
    Coluzzi F; Mattia C
    Minerva Anestesiol; 2010 Dec; 76(12):1072-84. PubMed ID: 21102402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of hydromorphone hydrochloride in healthy dogs.
    KuKanich B; Hogan BK; Krugner-Higby LA; Smith LJ
    Vet Anaesth Analg; 2008 May; 35(3):256-64. PubMed ID: 18282253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antinociceptive effects of intravenous administration of three doses of butorphanol tartrate or naloxone hydrochloride following hydromorphone hydrochloride to healthy conscious cats.
    Simon BT; Scallan EM; Baetge CL; Coursey CD; Lizarraga I
    Vet Anaesth Analg; 2019 Jul; 46(4):538-547. PubMed ID: 31171446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitors of cytochrome P450 differentially modify discriminative-stimulus and antinociceptive effects of hydrocodone and hydromorphone in rhesus monkeys.
    Lelas S; Wegert S; Otton SV; Sellers EM; France CP
    Drug Alcohol Depend; 1999 May; 54(3):239-49. PubMed ID: 10372797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.